Geneva, April 28 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122572) titled 'Study of the effect of lenalidomide on maintenance therapy for diffuse large B cell Lymphoma' on April 15.
Study Type: Interventional study
Study Design:
Historical control
Primary Sponsor: Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine
Condition:
Diffuse large B-cell lymphoma(DLBCL)
Intervention:
treatment group:Lenalidomide maintenance therapy (maintenance therapy for 2 years)
Recruitment Status: Recruiting
Phase: 4
Date of First Enrollment: 2025-04-18
Target Sample Size: treatment group:145;Complete remission after first-line systemic chemotherapy without maint...